Announcements
- FibroBiologics to Present at JonesTrading Healthcare Summit 2024
- FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid Technology
- FibroBiologics Set to Join Russell 2000® Index
- FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
- FibroBiologics Announces 2024 Annual Meeting of Stockholders
- FibroBiologics Files 2024 First Quarter Report
- FibroBiologics to Present at the BIO International Convention 2024
- FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids
- FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office
- FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA
More ▼
Key statistics
On Monday, Fibrobiologics Inc (SG0:FRA) closed at 4.08, 12.09% above the 52 week low of 3.64 set on Jul 02, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.08 |
---|---|
High | 4.08 |
Low | 4.08 |
Bid | -- |
Offer | -- |
Previous close | 4.08 |
Average volume | 0.00 |
---|---|
Shares outstanding | 35.72m |
Free float | 25.79m |
P/E (TTM) | -- |
Market cap | 192.53m USD |
EPS (TTM) | -1.03 USD |
Data delayed at least 15 minutes, as of Jul 22 2024 07:10 BST.
More ▼